|
|
Article: University of Cambridge and Life Technologies Collaborate on Landmark High Throughput Sequencing Hub in United Kingdom.
- Article from:
- Business Wire
- Article date:
- November 10, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Advanced Genomic Analysis Technology to Support Genomics and Biomedical Genetics Research
CARLSBAD, Calif. -- The University of Cambridge and Life Technologies Corporation (NASDAQ:LIFE), announced today the formation of a collaboration to advance translational research studies in key disease areas such as cancer, diabetes and neurological disorders. Through this collaboration, next generation sequencing technology will be made available to the European research and clinical communities through the Eastern Sequence and Informatics Hub at Addenbrooke's Hospital in Cambridge.
The Cambridge based hub was established with funding from the Medical Research ...